News
Lantheus shares fell 25% post-Q1 2025 report due to disappointing EPS guidance and not meet analysts' expectations. Click ...
The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback